HUMAN PHARMA
ActiveFrom the official registers: KBO 4 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
The computed 12-month bankruptcy probability of HUMAN PHARMA is 2.3% (moderate). The 2025 annual accounts show equity of €224,840 and a net result of €46,829. Equity is growing by about 37% per year across the filed financial years. Its solvency ranks better than 66% of 12,737 sector peers (NACE 47, financial year 2025). The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.
Directors
Mandate history
- Board
| Name | Functions and periods |
|---|---|
| NGANDEU NGONLEBEK Serge Aimé |
|
How the board is organised
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- Each director alone
- Board ruleHow the board is made up, meets and takes decisions.
- “Nommés avec ou sans limitation de durée, un ou plusieurs administrateurs,personnes physiques ou morales,actionnaires ou non”
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- One provision in the deed
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Designer liquidateurs fixer pouvoirs emoluments, administrateurs en fonction si aucun autre designe”
Articles of association, deed of 06-04-2023
Owners and capital
Capital and shareholders
- NGANDEU NGONLEBEK Serge Aimé 300 shares (100%) · €3,000 in cash
- 06-04-2023 Incorporation · €3,000 · 300 shares
Shares according to the articles of association
Capital, shares and profit
- Kind of sharesWhich classes of shares exist and what rights each class carries.
- “Nominatives, nature des actions”
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “Moitié à charge du cédant et moitié à charge du ou des acquéreurs,proportionnellement au nombre d’actions acquises, héritiers et légataires…”
- Share issue ruleHow and by whom new shares can be issued.
- “Apport en numéraire avec émission de nouvelles actions – droit de préférence, organe qui procède à l’émission”
Other provisionsRules from the articles on subjects other than the board, the shares, the purpose and the meetings.
Articles of association, deed of 06-04-2023 (in French)